Public Health Agency of Canada
Symbol of the Government of Canada
Help the Government of Canada organize its website! Complete an anonymous 5-minute questionnaire. Start now.

Share this page

ARCHIVED - Formative Evaluation of the Canadian HIV Vaccine Initiative

Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of CanadaExternal link, you can request alternate formats on the "Contact Us" page.

Management Response and Action Plan

  Evaluation Recommendations Management Response Management Action Plan Deliverables Expected Completion Date Responsibility Accountability Resources
1 The Interdepartmental Steering Committee take the opportunity of the recommendation of the Government of Canada and the Bill & Melinda Gates Foundation to not proceed with the Pilot Scale Manufacturing Capacity for Clinical Trial Lots component to re-examine the nature and scope of the Initiative and, as individual departments/ agencies, to re-examine their commitments to, and roles in, the Initiative, as well as the role of the Bill & Melinda Gates Foundation. Agree Interdepartmental Steering Committee to discuss the goals and objectives of the CHVI and the roles and responsibilities of the participating departments/ agencies and the Bill & Melinda Gates Foundation. Decision outlining specific responsibilities regarding nature and scope of the Initiative, and the roles of the individual departments/agencies and the Bill & Melinda Gates Foundation. December 2010 - June 2011 The Director Generals of each of the partnering departments (CIDA, PHAC, Industry, CIHR, Health Canada). Director General, Centre for Communicable Diseases and Infection Control, PHAC N/A. The tasks will be consumed within the current funding and delivery practice.
2 The Interdepartmental Steering Committee seek an extension to the Initiative beyond 2012/13, ensuring that there is sufficient flexibility in the Initiative to allow it to remain consistent over time with the global efforts to achieve an HIV vaccine. Agree Interdepartmental Steering Committee to seek authorities to extend the initiative. Decision regarding an extension of the CHVI. December 2010 Director General, CCDIC, PHAC Director General, Centre for Communicable Diseases and Infection Control, PHAC TBD
3 As part of the re-examination of the nature and scope of the Initiative, the Interdepartmental Steering Committee identify clear expectations and timelines with respect to the delivery responsibilities of the participating departments/ agencies in order to overcome the factors that have contributed to the delays to date in the Initiative. Agree Interdepartmental Steering Committee to address implementation issues that resulted in delays and put in place measures to mitigate those issues
(i.e. lack of explicit agreements between departments/ agencies regarding implementation, lack of engagement of some stakeholders, high staff turnover in some depts.)
Action plan December 2010 The Director Generals of each of the partnering departments (CIDA, PHAC, Industry, CIHR, Health Canada). Director General, Centre for Communicable Diseases and Infection Control, PHAC N/A. The tasks will be consumed within the current funding and delivery practice.
4 The Interdepartmental Steering Committee put in place measures to communicate effectively with external stakeholders, through both the CHVI website and clear messaging from the participating departments/ agencies. Agree Development of a Communications Engagement Strategy Communications Engagement Strategy December 2010 The Director Generals of each of the partnering departments (CIDA, PHAC, Industry, CIHR, Health Canada). Director General, Centre for Communicable Diseases and Infection Control, PHAC N/A. The tasks will be consumed within the current funding and delivery practice.
5 The Interdepartmental Steering Committee re-examine the structure of the CHVI governing bodies, notably the Interdepartmental Steering Committee, to ensure that there is adequate authority and capacity to provide the necessary interdepartmental leadership. Agree Interdepartmental Steering Committee and Bill & Melinda Gates Foundation to review the governance structure and identify recommendations for the future. Revised governance structure December 2010 The Director Generals of each of the partnering departments (CIDA, PHAC, Industry, CIHR, Health Canada) Director General,
Centre for Communicable Diseases and Infection Control, PHAC
N/A. The tasks will be consumed within the current funding and delivery practice.
6 The Secretariat, working with the program-level Interdepartmental Committee, review the existing RMAF/RBAF to ensure that it remains relevant and clearly identifies departments/ agencies responsibilities for all components to the outcomes; and ensure that the RMAF/RBAF is implemented to provide sufficient data for the next evaluation. Agree. Review existing RMAF/RBAF and identify areas to be improved Revised performance measurement framework March 2011 Director, CHVI Secretariat (PHAC) Director General, Centre for Communicable Diseases and Infection Control, PHAC N/A. The tasks will be consumed within the current funding and delivery practice.